Aethion Medical Inc. (AEMD) Stock Quote

Detailed Quote for Aethion Medical Inc. (AEMD)

close 52 Week Information

52 Week High

March 8, 2011

Close: 0.185

52 Week Low

September 13, 2011

Close: 0.0375

Today

Last Price
0.068

Change $
0.001

Change %
1.45%

Tick
N/A

Bid
0.06

Bid Size
5,000

Ask
0.11

Ask Size
10,000

Open
0.067

High
0.07

Low
0.067

Prev Close
0.069

Last Trade
2/10/12

Volume
168.96 k

52 Wk Hi
0.185

52 Wk Low
0.0375

Market Cap
7.38 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
108,471,606

EPS (TTM)
-0.02

PE Ratio
N/A

close Exchange Information Listed On OTC Bulletin Board Consolidated (OTCBB) Exchange
OTCBB

News and Media for Aethion Medical Inc. (AEMD)

Sector News | Topic News

News for AEMD

Tue, Feb 07, 2012

8:15 AM

Aethlon Medical to Present Hepatitis C (HCV) Treatment Technology at the 32nd Annual Dialysis Conference - PR Newswire

Wed, Feb 01, 2012

7:33 AM

Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol - PR Newswire

Mon, Jan 23, 2012

9:13 AM

Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board - PR Newswire

Thu, Jan 12, 2012

8:00 AM

Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board - PR Newswire

Mon, Jan 09, 2012

2:19 PM

Aethlon Medical Discloses Availability of the Biotech Showcase(tm) 2012 Presentation - PR Newswire

Wed, Jan 04, 2012

1:44 PM

Aethlon Medical Announces Biotech Showcase(tm) 2012 Presentation - PR Newswire

Tue, Dec 13, 2011

7:30 AM

Aethlon Medical Announces HIV-AIDS Research Discovery - PR Newswire

Tue, Dec 06, 2011

9:15 AM

Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes - PR Newswire

Wed, Nov 16, 2011

9:30 AM

Aethlon Medical Releases Shareholder Letter - PR Newswire

Tue, Oct 25, 2011

8:30 AM

Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th - PR Newswire

Tue, Oct 18, 2011

9:15 AM

Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community - PR Newswire

Wed, Oct 05, 2011

9:15 AM

Aethlon Medical Announces Hemopurifier® and HER2osome(tm) Cancer Therapy Presentation at Exosomes and Microvesicles 2011 - PR Newswire

Mon, Oct 03, 2011

8:00 AM

Aethlon Medical Receives Government Contract Award from DARPA - PR Newswire

Tue, Sep 27, 2011

9:15 AM

"A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression" Released by Aethlon Medical, Inc. - PR Newswire

Wed, Sep 21, 2011

7:00 AM

Aethlon Medical Introduces HER2osome(tm), A Novel Therapeutic Device Strategy to Address Breast Cancer - PR Newswire

Fri, Feb 18, 2011

4:35 PM

AllPennyStocks.com Announces February 21st to February 25th U.S. Penny Stocks 2 Watch (AEMD.OB, HHWW.OB) - Accesswire

More News for AEMD >>

Tags for Aethion Medical Inc.

Research stocks or mutual funds related to Aethion Medical Inc. by keywords or tags. Find companies that have a similar focus to AEMD. The keywords below have been associated to AEMD by either user submission or electronic means.

medical studies clinical trials database clinical trial enrollment clinical trials liability clinical trials vacancies clinical research trial corporate awards clinical trials data infectious disease medical device design fda registration employee awards hiv rash performance awards medical product clinical pharmacology clinical research consulting trail clinical fundamentals of clinical trials fda 510k corporate communications awards stock markets novel awards engraved awards medical supplies equipment medical device contract manufacturing clinical trials uk darwin awards 2006 bronze awards hiv early symptoms lucite awards infectious diseases phase iii clinical trials fun employee awards romania clinical research Hepatitis C symptoms of hiv hiv testing fda qsr medical device testing clinical research infectious disease specialist enrollment clinical trials excellence awards fda regulation infectious disease doctor technology research restricted stock awards architectural awards phase 3 clinical trials